Upending decades-old guidance, the Centers for Disease Control and Prevention’s vaccine advisory committee voted to no longer issue a blanket recommendation that all newborns receive a hepatitis B vaccine at birth. Throughout the meeting, many panelists made misleading claims about the vaccine.
The vaccine advisory committee of the Centers for Disease Control and Prevention is scheduled to meet Dec. 4 and 5. On the agenda: the hepatitis B vaccine, the overall childhood vaccine schedule and specific vaccine ingredients. We’ll summarize what we’ve written about these topics and what the committee has said about them in recent meetings.
An hourlong press conference about autism was filled with false and misleading claims about the condition and vaccines from President Donald Trump and Health and Human Services Secretary Robert F. Kennedy Jr., many of which we have written about before.
The chair of Robert F. Kennedy Jr.’s newly constituted vaccine advisory committee announced in his first meeting that the panel will revisit the longstanding practice of vaccinating all babies against hepatitis B, questioning whether it was “wise” to administer shots “to every newborn before leaving the hospital.” Experts, however, say there are valid reasons to vaccinate babies against hepatitis B, and that it has proven to be safe and very effective.